论文部分内容阅读
日本是传统医药的一大消费市场。自1976年开始,210种汉方制剂逐步被纳入日本的国民健康保险体系,随之日本的药用植物栽培业、汉方制药产业得到了迅速的发展,成为中国之外生产天然药物制剂的另一大国。本文通过对日本传统医药现状、日本药用植物的栽培与生产、产品开发等方面的考察与分析,希望能为香港和中国内地中药业发展及开拓国际市场提供一些参考。
Japan is a major consumer market for traditional medicine. Since the beginning of 1976, 210 Kampo preparations have gradually been incorporated into Japan’s National Health Insurance System. As a result, Japan’s pharmaceutical plant cultivation industry and Hanfang pharmaceutical industry have been rapidly developed, and have become an alternative to natural pharmaceutical preparations outside China. A big country. This article aims to provide some references for the development of the Chinese medicine industry in Hong Kong and Mainland China and for the development of the international market by examining and analyzing the status quo of traditional medicine in Japan, cultivation and production of Japanese medicinal plants, and product development.